Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1986-04-22
1990-01-09
Tarcza, John Edward
Chemistry: molecular biology and microbiology
Spore forming or isolating process
435948, 43524025, C12N 500, C12N 1500, C12R 191
Patent
active
048928291
ABSTRACT:
Using a serum-free defined medium, a human cell line, NCI-H929, was established from a malignant effusion occuring in a patient with IgAk myeloma. The cultured cells have the morphologic, ultrastructural, biochemical, immunologic and cytochemical features of plasma cells. The cells have rearranged alpha and kappa genes and synthesize and secrete very high amounts of IgAk (>80 .mu.g/10.sup.6 cells/24 hr). The cells express surface immunoglobulin (alpha and kappa), the plasma cell antigen PCA-1, the transferrin receptor (T9) and T10, but lack antigens associated with earlier stages of B cell development (HLA-DR, B1, B2, B4, CALLA), as well as other leukocyte-macrophage antigens and Epstein-Barr virus nuclear antigen. While the tumor cells were predominantly near-diploid, the cultured cells are predominantly near-tetraploid with six copies of chromosome 8, four to six of which have an 8q+ abnormality. The cultured cells have a rearrangement of the cellular c-myc proto-oncogene (located at 8q24) and express c-myc RNA.
REFERENCES:
patent: 4434230 (1984-02-01), Ritts, Jr.
patent: 4542096 (1985-09-01), Leder
Benjamin et al, Proc. Natl. Acad. Sci. 81, pp. 3547-3551 (1984).
Adams et al, Proc. Natl. Acad. Sci. 80, pp. 1982-1986 (1983).
Bernard et al, E.M.B.O. Journal 2(12), pp. 2375-2383 (1983).
Nilsson, et al. Clin Exp. Immunol., (1970) 7, 477-489, Established Immunologlobulin Producing Myeloma (IgE) and Lymphoblastoid (IgG) Cell Lined from an IgE Myeloma Patient.
Karpas, et al. Science, vol. 216, May 28, 1982, 997-999, Human Myeloma Cell Line Carrying a Philadelphia Chromosome.
Matsuoka, et al., P.S.E.B.M., 1967, V. 125, May 8, 1967, 1246-1250, Production of Free Light Chains of Immunoglobulin by a Hemapoietic Cell Line Derived from a Patient with Multiple Myeloma.
Gazdar Adi F.
Oie Herbert K.
Tarcza John Edward
The United States of America as represented by the Secretary of
LandOfFree
Human plasma cell line having rearranged c-myc proto-oncogene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human plasma cell line having rearranged c-myc proto-oncogene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human plasma cell line having rearranged c-myc proto-oncogene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-145320